SCHEMBL164542

SCHEMBL164542

CCN(C(C)=O)C1CCN(S(=O)(=O)c2ccc(NC(=O)NCc3cccnc3)cc2)C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 20/20 1.00
CYP2C9 P11712 4/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL164541 1.00 NAMPT (1.00) NAMPTCYP2C9
SCHEMBL174523 0.87 NAMPT (1.00) NAMPTCYP2C9
SCHEMBL29635798 0.84 NAMPT (1.00) NAMPTCYP2C9
SCHEMBL163139 0.84 NAMPT (1.00) NAMPTCYP2C9
SCHEMBL12503625 0.83 NAMPT (0.75) NAMPTCYP2C9
SCHEMBL163455 0.83 NAMPT (0.75) NAMPTCYP2C9
SCHEMBL163456 0.83 NAMPT (0.75) NAMPTCYP2C9
SCHEMBL29635819 0.83 NAMPT (1.00) NAMPTCYP2C9
SCHEMBL167267 0.83 NAMPT (1.00) NAMPTCYP2C9
SCHEMBL29635783 0.82 NAMPT (1.00) NAMPTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611777-A1 4- { [ ( PYRIDIN- 3 - YL -METHYL) AMINOCARBONYL]AMINO} BENZENE - SULFONE DERIVATIVES AS NAMPT INHIBITORS FOR THERAPY OF DISEASES SUCH AS CANCER Forma TM, LLC. (US) 2013-07-10 EP disclosed
WO-2012031196-A9 4- { [ ( PYRIDIN- 3 - YL -METHYL) AMINOCARBONYL] AMINO} BENZENE - SULFONE DERIVATIVES AS NAMPT INHIBITORS FOR THERAPY OF DISEASES SUCH AS CANCER FORMA TM, LLC (US) 2013-06-13 WO disclosed
WO-2012031196-A1 4- { [ ( PYRIDIN- 3 - YL -METHYL) AMINOCARBONYL] AMINO} BENZENE - SULFONE DERIVATIVES AS NAMPT INHIBITORS FOR THERAPY OF DISEASES SUCH AS CANCER FORMA THERAPEUTICS, INC. (US) 2012-03-08 WO disclosed